CytoDyn Inc. (CYDY)
OTCMKTS: CYDY · Delayed Price · USD
+0.002 (1.00%)
Apr 23, 2024, 12:39 PM EDT - Market open

CytoDyn Statistics

Total Valuation

CytoDyn has a market cap or net worth of $150.59 million. The enterprise value is $178.19 million.

Market Cap 150.59M
Enterprise Value 178.19M

Important Dates

The last earnings date was Monday, January 9, 2023.

Earnings Date Jan 9, 2023
Ex-Dividend Date n/a

Share Statistics

CytoDyn has 993.37 million shares outstanding. The number of shares has increased by 18.02% in one year.

Shares Outstanding 993.37M
Shares Change (YoY) +18.02%
Shares Change (QoQ) +2.42%
Owned by Insiders (%) 0.80%
Owned by Institutions (%) 0.02%
Float 979.97M

Valuation Ratios

PE Ratio n/a
Forward PE 10.81
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.08

Current Ratio 0.08
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 4.28

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -503.31%
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$4.31M
Employee Count 12
Asset Turnover n/a
Inventory Turnover n/a


In the past 12 months, CytoDyn has paid $26.38 million in taxes.

Income Tax 26.38M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -50.00% in the last 52 weeks. The beta is 0.19, so CytoDyn's price volatility has been lower than the market average.

Beta (1Y) 0.19
52-Week Price Change -50.00%
50-Day Moving Average 0.17
200-Day Moving Average 0.19
Relative Strength Index (RSI) 42.67
Average Volume (30 Days) 2,906,443

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit -35,000
Operating Income -15.20M
Pretax Income -51.69M
Net Income -51.69M
EBITDA -38.61M
EBIT -38.64M
Earnings Per Share (EPS) -$0.05
Full Income Statement

Balance Sheet

The company has $1.40 million in cash and $30.49 million in debt, giving a net cash position of -$29.08 million or -$0.03 per share.

Cash & Cash Equivalents 1.40M
Total Debt 30.49M
Net Cash -29.08M
Net Cash Per Share -$0.03
Equity / Book Value -119.38M
Book Value Per Share -0.12
Working Capital -119.57M
Full Balance Sheet

Cash Flow

Operating Cash Flow -12.74M
Capital Expenditures n/a
Free Cash Flow -12.74M
FCF Per Share -$0.01
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CytoDyn does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -18.02%
Shareholder Yield -18.02%
Earnings Yield -34.67%
FCF Yield -8.55%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Altman Z-Score n/a
Piotroski F-Score 2